PREMIUM
Health
Uganda to try six-month long-lasting injectable ARV
The Gilead Women’s PrEP Study will enroll about 5,000 participants — only adolescent girls and young women at high risk of HIV infection.
Uganda to try six-month long-lasting injectable ARV
By: NewVision Reporter, Journalists @NewVision
After a successful trial that gave the world a long-term injectable antiretroviral (ARV), Cabotegravir, Uganda is set for another study on another injectable that can last six months. Cabotegravir was